MGVS develops
therapeutic
products that address blood vessel disorders.
Our products uniquely target patients
who cannot be treated adequately with current therapeutic modalities.
Leading
products
MultiGene
Angio: A cell therapy
product for alleviating symptoms and signs of ischemia
in patients
with peripheral arterial disease (PAD).
MultiGene
Graft:
A biosynthetic vascular graft providing improved biocompatibility for PAD patients undergoing bypass surgery and for renal disease patients who need an access site for hemodialysis.
